Literature DB >> 23740148

Whole blood lactate kinetics in patients undergoing quantitative resuscitation for severe sepsis and septic shock.

Michael A Puskarich1, Stephen Trzeciak2, Nathan I Shapiro3, Andrew B Albers4, Alan C Heffner4, Jeffrey A Kline4, Alan E Jones5.   

Abstract

BACKGROUND: We sought to compare the association of whole-blood lactate kinetics with survival in patients with septic shock undergoing early quantitative resuscitation.
METHODS: This was a preplanned analysis of a multicenter, ED-based, randomized, controlled trial of early sepsis resuscitation. Inclusion criteria were suspected infection, two or more systemic inflammation criteria, either systolic BP< 90 mm Hg after a fluid bolus or lactate level > 4 mM, two serial lactate measurements, and an initial lactate level > 2.0 mM. We calculated the relative lactate clearance, rate of lactate clearance, and occurrence of early lactate normalization (decline to < 2.0 mM in the first 6 h). Area under the receiver operating characteristic curve (AUC) and multivariate logistic regression were used to determine the lactate kinetic parameters that were the strongest predictors of survival.
RESULTS: The analysis included 187 patients, of whom 36% (n = 68) normalized their lactate level. Overall survival was 76.5% (143 of 187 patients), and the AUC of initial lactate to predict survival was 0.64. The AUCs for relative lactate clearance and lactate clearance rate were 0.67 and 0.58, respectively. Lactate normalization was the strongest predictor of survival (adjusted OR, 5.2; 95% CI, 1.7-15.8), followed by lactate clearance ≥ 50% (OR, 4.0; 95% CI, 1.6-10.0). Lactate clearance ≥ 10% (OR, 1.6; 95% CI, 0.6-4.4) was not a significant independent predictor in this cohort.
CONCLUSIONS: In patients in the ED with a sepsis diagnosis, early lactate normalization during the first 6 h of resuscitation was the strongest independent predictor of survival and was superior to other measures of lactate kinetics. TRIAL REGISTRY: ClinicalTrials.gov; No.: NCT00372502; URL: clinicaltrials.gov.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23740148      PMCID: PMC3673659          DOI: 10.1378/chest.12-0878

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  21 in total

1.  Counterpoint: should lactate clearance be substituted for central venous oxygen saturation as goals of early severe sepsis and septic shock therapy? No.

Authors:  Emanuel P Rivers; Ronald Elkin; Chad M Cannon
Journal:  Chest       Date:  2011-12       Impact factor: 9.410

2.  Point: should lactate clearance be substituted for central venous oxygen saturation as goals of early severe sepsis and septic shock therapy? Yes.

Authors:  Alan E Jones
Journal:  Chest       Date:  2011-12       Impact factor: 9.410

3.  Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care.

Authors:  D C Angus; W T Linde-Zwirble; J Lidicker; G Clermont; J Carcillo; M R Pinsky
Journal:  Crit Care Med       Date:  2001-07       Impact factor: 7.598

4.  Prognostic value of blood lactate levels: does the clinical diagnosis at admission matter?

Authors:  Tim C Jansen; Jasper van Bommel; Paul G Mulder; Alexandre P Lima; Ben van der Hoven; Johannes H Rommes; Ferdinand T F Snellen; Jan Bakker
Journal:  J Trauma       Date:  2009-02

5.  Multicenter study of early lactate clearance as a determinant of survival in patients with presumed sepsis.

Authors:  Ryan C Arnold; Nathan I Shapiro; Alan E Jones; Christa Schorr; Jennifer Pope; Elisabeth Casner; Joseph E Parrillo; R Phillip Dellinger; Stephen Trzeciak
Journal:  Shock       Date:  2009-07       Impact factor: 3.454

6.  Prognostic value and agreement of achieving lactate clearance or central venous oxygen saturation goals during early sepsis resuscitation.

Authors:  Michael A Puskarich; Stephen Trzeciak; Nathan I Shapiro; Ryan C Arnold; Alan C Heffner; Jeffrey A Kline; Alan E Jones
Journal:  Acad Emerg Med       Date:  2012-03       Impact factor: 3.451

7.  Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial.

Authors:  Alan E Jones; Nathan I Shapiro; Stephen Trzeciak; Ryan C Arnold; Heather A Claremont; Jeffrey A Kline
Journal:  JAMA       Date:  2010-02-24       Impact factor: 56.272

8.  Early lactate-guided therapy in intensive care unit patients: a multicenter, open-label, randomized controlled trial.

Authors:  Tim C Jansen; Jasper van Bommel; F Jeanette Schoonderbeek; Steven J Sleeswijk Visser; Johan M van der Klooster; Alex P Lima; Sten P Willemsen; Jan Bakker
Journal:  Am J Respir Crit Care Med       Date:  2010-05-12       Impact factor: 21.405

Review 9.  The effect of a quantitative resuscitation strategy on mortality in patients with sepsis: a meta-analysis.

Authors:  Alan E Jones; Michael D Brown; Stephen Trzeciak; Nathan I Shapiro; John S Garrett; Alan C Heffner; Jeffrey A Kline
Journal:  Crit Care Med       Date:  2008-10       Impact factor: 7.598

Review 10.  Blood lactate monitoring in critically ill patients: a systematic health technology assessment.

Authors:  Tim C Jansen; Jasper van Bommel; Jan Bakker
Journal:  Crit Care Med       Date:  2009-10       Impact factor: 7.598

View more
  46 in total

1.  The Challenge and the Promise of Studying Mitochondrial Dysfunction in Humans with Sepsis.

Authors:  Michael A Puskarich
Journal:  Ann Am Thorac Soc       Date:  2015-11

2.  Incidence and impact of skin mottling over the knee and its duration on outcome in critically ill patients.

Authors:  Rémi Coudroy; Angéline Jamet; Jean-Pierre Frat; Anne Veinstein; Delphine Chatellier; Véronique Goudet; Severin Cabasson; Arnaud W Thille; René Robert
Journal:  Intensive Care Med       Date:  2014-12-17       Impact factor: 17.440

Review 3.  Thermoregulation as a disease tolerance defense strategy.

Authors:  Alexandria M Palaferri Schieber; Janelle S Ayres
Journal:  Pathog Dis       Date:  2016-11-03       Impact factor: 3.166

4.  The Diagnosis and Hemodynamic Monitoring of Circulatory Shock: Current and Future Trends.

Authors:  Adham Hendy; Şerban-Ion Bubenek-Turconi
Journal:  J Crit Care Med (Targu Mures)       Date:  2016-08-10

5.  Clinical predictors of early death from sepsis.

Authors:  Adnan Javed; Faheem W Guirgis; Sarah A Sterling; Michael A Puskarich; Jennifer Bowman; Taylor Robinson; Alan E Jones
Journal:  J Crit Care       Date:  2017-06-23       Impact factor: 3.425

6.  Early alterations in platelet mitochondrial function are associated with survival and organ failure in patients with septic shock.

Authors:  Michael A Puskarich; Jeffrey A Kline; John A Watts; Kristin Shirey; Jonathan Hosler; Alan E Jones
Journal:  J Crit Care       Date:  2015-10-26       Impact factor: 3.425

7.  Clearing lactate is clearly better…but how much?*.

Authors:  Michael A Puskarich; Alan E Jones
Journal:  Crit Care Med       Date:  2014-09       Impact factor: 7.598

Review 8.  Lactate, a useful marker for disease mortality and severity but an unreliable marker of tissue hypoxia/hypoperfusion in critically ill patients.

Authors:  Shigeki Kushimoto; Satoshi Akaishi; Takeaki Sato; Ryosuke Nomura; Motoo Fujita; Daisuke Kudo; Yu Kawazoe; Yoshitaro Yoshida; Noriko Miyagawa
Journal:  Acute Med Surg       Date:  2016-05-16

9.  Predictive value of lactate in unselected critically ill patients: an analysis using fractional polynomials.

Authors:  Zhongheng Zhang; Kun Chen; Hongying Ni; Haozhe Fan
Journal:  J Thorac Dis       Date:  2014-07       Impact factor: 2.895

10.  Repeat lactate level predicts mortality better than rate of clearance.

Authors:  Zachary D W Dezman; Angela C Comer; Gordon S Smith; Peter F Hu; Colin F Mackenzie; Thomas M Scalea; Jon Mark Hirshon
Journal:  Am J Emerg Med       Date:  2018-03-07       Impact factor: 2.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.